TIERCFO Β· TIERCFO.COM
πŸ”₯ 2026–2027 BREAKOUT SCENARIO: Physicians, NPs & Healthcare Entrepreneurs Opening Cash-Pay Longevity Clinics +510% YoY Search Growth

2026 Longevity, GLP-1 Weight Loss, Peptide & IV Drip Cash-Pay Clinic 5-Year SBA 7(a) Financial Model

Recurring Membership MRR, Compounding Pharmacy COGS, MSO-PC Legal Structure & 2.15x DSCR Underwriting Benchmark

Key Parameter / ComponentConventional Baseline / Risk2026 Optimal Target / BenchmarkActionable Execution Protocol
Startup Buildout + Diagnostic Equipment$180,000 – $350,000 SBA 7(a) Loan10-Year Term @ Prime + 2.50%Covers DEXA/VO2 Max scanner + 4 IV bays + working cap
Blended Gross Margin (GLP-1 / TRT / IV)74.0% – 81.5% Gross Margin503A/503B Pharmacy + Lab Panel COGS: 21%Recurring $299–$499/mo membership stabilizes cashflow
Year-1 Projected EBITDA & Bank DSCR$265,000 EBITDA on $890,000 Revenue2.38x DSCR (Exceeds 1.25x SBA threshold)Passes SBA SOP 50 10 7.1 healthcare cashflow audit
⚑ INSTANT SCENARIO SIMULATOR & 1-CLICK UNLOCK  Apple Pay · G Pay · PayPal · Instant PDF/Excel

Apply This Exact Scenario to Your Custom TierCFO Dossier:

Scenario Locked: 2026 Longevity, GLP-1 Weight Loss, Peptide & IV Drip Cash-Pay Clinic 5-Year SBA 7(a) Financial Model

Target Bank Underwriting DSCR & 5-Year Model Status:
1.85x – 2.35x DSCR (βœ“ SBA SOP 50 10 7.1 Ready)
Includes Main Printable PDF/Excel + 2 VIP Bonus Guides (No Subscription)
READY 2026 Longevity, GLP-1 Weight Loss, Peptide & IV Drip Cash-Pay Clinic 5-Year SBA 7(a) Financial Model
Application Scenario & Execution Blueprint: SBA Underwriting Application Scenario: Cash-pay longevity, hormone replacement (TRT/HRT), and medical weight-loss clinics are the #1 fastest-growing healthcare SBA 7(a) loan category in 2026 due to zero insurance-reimbursement delay.
INSTANT INTERACTIVE GENERATOR & VIP DOSSIER
Customize & Download Your Full TierCFO Protocol / Model in 60 Seconds
Open TierCFO Interactive Calculator β†’

Related TierCFO Quantitative Monographs & Multilingual Hubs